Search

everythinglearnresearchcommunity

for

Search:↓

Long-pulsed ruby laser effectively reduces hair in male-to-female transsexuals.

Hair loss and excessive growth treated with various options, including new laser technology.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Women with PCOS often have irregular periods, a higher chance of infertility and miscarriages, and may improve fertility with lifestyle changes and treatment.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

The treatment effectively reduces menopausal symptoms and is well tolerated.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone therapy increases bone density in older men with low testosterone levels.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

PCOS is influenced by various factors and may be managed by restoring gut health and using new therapies.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Testosterone increases seizure risk through its conversion to specific neurosteroids.